How are next-generation anti-VEGF agents changing care in AMD, DME, and RVO? Sharon Fekrat, MD, FACS, FASRS, and an expert panel discuss the real-world performance, durability, and safety of aflibercept 8 mg and faricimab. Watch now: https://t.co/WOXWmHX6Tt #Retina#AntiVEGF
As aesthetic injectables continue to grow in popularity, retina specialists are increasingly likely to encounter patients considering these procedures. Watch the latest episode of The Retina TL;DR to learn more: https://t.co/7c6A1iDtVs
Jennifer Murdock, MD, joins The Retina TL;DR with Christina Y. Weng, MD, MBA, FASRS, to discuss filler-related ocular complications, high-risk injection sites, emergency management strategies, and more. Watch now: https://t.co/5qWPIGeG4q
Watch Christina Y. Weng, MD, MBA, FASRS, and her guest Jennifer Murdock, MD, discuss anatomy, vascular occlusion risk, and periocular filler safety in the latest episode of The Retina TL;DR: https://t.co/rK30NH1d8d
Prevent Blindness has designated April as Women’s Eye Health and Safety Month. We are proud to support this initiative and highlight the voices shaping the future of care. Explore insights from female key opinion leaders whose recent work is featured on our platforms.
We are hosting two events for retina specialists in Fort Lauderdale, FL, on May 15. Participants will receive $500 in compensation. Learn more and join us!
Geographic Atrophy Roundtable: https://t.co/Om5ahXElhd
Anti-VEGF Roundtable: https://t.co/84AUVkPU5C
Honoring the women who are shaping the future of vision. From groundbreaking research to everyday patient care, their leadership and dedication continue to move the field forward. This Women’s History Month, we recognize their impact across every corner of eye care.
Check out the latest issue of Modern Retina! Read about how AI is reshaping ophthalmology, mitigating severe vision loss, multimodal imaging for AMD and GA, as well as mentorship, momentum, and a retina podcast.
Read now: https://t.co/ysbi4bif3E
#Retina#VisionLoss#AMD#GA
Disease mechanisms and treatment goals differ across AMD, DME, and RVO. Our expert panel reviews clinical nuances and how they guide the choice of next-generation anti-VEGF therapy.
Watch the discussion: https://t.co/F3kQy2OYJo
#Retina#Ophthalmology
Our latest issue is live! Read about the science powering next-generation retinal treatments, custom programs for managing Macular Telangiectasia, and treatment options for reducing fluid fluctuation in retinal disorders.
Read now: https://t.co/hHjPk27uT5
#Retina#MacTel
How are next-generation anti-VEGF agents changing care in AMD, DME, and RVO? Sharon Fekrat, MD, FACS, FASRS, and an expert panel discuss the real-world performance, durability, and safety of aflibercept 8 mg and faricimab.
Watch now: https://t.co/ZOBoo24a95
#Retina#AntiVEGF
Wishing you a season filled with clear moments and bright perspectives. 🎄👁️
Thank you to the retina specialists whose precision and dedication protect sight at its most critical level, today and all year long.
#EyeCareProfessionals#RetinaCare#HappyHolidays
Grateful for the eye-care professionals who bring clarity, comfort, and better vision to patients every day. Wishing you a spec-tacular 👓 and restorative Thanksgiving! 🦃
#thanksgiving#eyecare
Coave Therapeutics has announced its lead gene therapy program, CoTx-10, for the treatment of retinal vascular diseases, such as wet age-related macular degeneration (wAMD) and diabetic macular edema (DME). https://t.co/OWZfO566ou
Stephen Tsang, MD, PhD, reviews promising optogenetic therapy results for retinitis pigmentosa and Stargardt disease, enhancing vision and mobility for patients. https://t.co/6KSZD9ZCzM